arrow
C

Clive Roper

roper toxicology consulting limited
H指数:16
被引数:879

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development

超越NAMs与动物模型:使用情境作为药物开发中综合非临床策略的指导框架

2026-09-010
PRE
The Decision Tree approach as a strategy for the global phase out of animal testing for acute and local toxicity for chemicals: recommendations from an expert workshop

决策树方法作为全球逐步淘汰化学物质急性及局部毒性动物实验的策略:专家研讨会的建议

2025-10-220
OAAI
The Use of MPS in Three Rs and Regulatory Applications: Perspectives From Developers on Stakeholder Responsibilities

MPS在“三R”原则和监管应用中的使用:来自开发者的利益相关方责任视角

2025-01-071
PRE
New approach methodologies (NAMs) for the in vitro assessment of cleaning products for respiratory irritation: workshop report

用于呼吸刺激的清洁产品体外评估的新方法方法 (NAMs): 研讨会报告

2024-10-080
OAAI
Minimum information for reporting on the TEER (trans-epithelial/endothelial electrical resistance) assay (MIRTA)
2024-10-040
OAAI
Assessing the safety of cosmetic chemicals: Consideration of a flux decision tree to predict dermally delivered systemic dose for comparison with oral TTC (Threshold of Toxicological Concern)

评估化妆品化学品的安全性: 考虑使用通量决策树来预测皮肤输送的全身剂量,以与口服TTC (毒理学关注阈值) 进行比较

2016-04-0141
OAAI